Search
for
Sort by
Research 30 of 135
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Compliance With Contraceptives and Other Treatments
- Organotypic Skin Culture
- Endocrinological evaluation and hormonal therapy for women with difficult acne
- Isolated eyebrow and eyelash trichotillomania mimicking alopecia areata
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Androgenic effects of oral contraceptives: Implications for patient compliance
- 5 Dihydrotestosterone metabolism
- Oral Contraceptives as Anti-Androgenic Treatment of Acne
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- [Cutaneous effects in hormonal contraception].
- Treatment guidelines in adult women
- Prenatal and prepubertal exposures to organochlorine compounds and perfluoroalkyl substances and pubertal development at age 12: The PELAGIE cohort study
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Hormonal Treatment for Skin Androgen-Related Disorders
- ‘The pill’: pimples, pigmentation and alopecia?
- [Contraceptive methods for adolescents].
- Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
- Balancing Hormones and Skin Health: A Focus on Oral Contraceptives in Dermatology
- Obsessive-compulsive skin disorders: a novel classification based on degree of insight
- Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
- Hormonal contraceptives: pharmacology tailored to women's health
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Cardiovascular risk factors and events in women with androgen excess
- Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females